Home
Third Rock Ventures V, 10% Owner: Rapport Therapeutics RAPP Sell · Filed 04/21
Trade details
- Type
- Insider sale
- Amount
- $17,176,521.6
- Shares · price
- 426,005 sh · $40.32 a share
- Held after
- 6,709,228 sh
- Trade date
- 26/04/17
- Filed
- 26/04/21
- Days to filing
- 4 days
Sold 6.0% of holdings
- Share of holding sold
- 6.0%
Rapport Therapeutics trades, last 26 weeks
What else happened in Rapport Therapeutics around then
Filed or reported within 30 days of the trade day · 03/18~05/17Third Rock Ventures V's recent trades
- Third Rock Ventures V
Planned sale10b5-1 planSepterna
Planned sale10b5-1 planSepterna
SEPN
$7.5M
147,200 sh
$7.5M
Filed 08/12
Traded 08/12
- Third Rock Ventures V
Sell10b5-1 planRapport Therapeutics
Sell10b5-1 planRapport Therapeutics
RAPP
$743.8K
18,572 sh
$743.8K
Filed 05/28
Traded 05/26
- Third Rock Ventures V
Planned saleRapport Therapeutics
Planned saleRapport Therapeutics
RAPP
$742.9K
18,572 sh
$742.9K
Filed 05/27
Traded 05/26
- Third Rock Ventures V
Sell10b5-1 planRapport Therapeutics
Sell10b5-1 planRapport Therapeutics
RAPP
$5.4M
133,618 sh
$5.4M
Filed 05/13
Traded 05/11
- Third Rock Ventures V
Sell10b5-1 planRapport Therapeutics
Sell10b5-1 planRapport Therapeutics
RAPP
$10.9M
271,495 sh
$10.9M
Filed 05/11
Traded 05/07
